The epigenetic reader PHF21B modulates murine social memory and synaptic plasticity-related genes

Synaptic dysfunction is a manifestation of several neurobehavioral and neurological disorders. A major therapeutic challenge lies in uncovering the upstream regulatory factors controlling synaptic processes. Plant homeodomain (PHD) finger proteins are epigenetic readers whose dysfunctions are implicated in neurological disorders. However, the molecular mechanisms linking PHD protein deficits to disease remain unclear. Here, we generated a PHD finger protein 21B-depleted (Phf21b-depleted) mutant CRISPR mouse model (hereafter called Phf21b(Delta 4/Delta a)) to examine Phf2lb's roles in the brain. Phf21b(Delta 4/Delta a) animals exhibited impaired social memory. In addition, reduced expression of synaptic proteins and impaired long-term potentiation were observed in the Phf21b(Delta 4/Delta a) hippocampi. Transcriptome profiling revealed differential expression of genes involved in synaptic plasticity processes. Furthermore, we characterized a potentially novel interaction of PHF21B with histone H3 trimethylated lysine 36 (H3K36me3), a histone modification associated with transcriptional activation, and the transcriptional factor CREB. These results establish PHF21B as an important upstream regulator of synaptic plasticity-related genes and a candidate therapeutic target for neurobehavioral dysfunction in mice, with potential applications in human neurological and psychiatric disorders.

Automated summary

Synaptic dysfunction is a manifestation of various disorders. This study focuses on the role of PHD finger protein 21B (Phf21b) in synaptic processes and identifies Phf21b as an important regulator of synaptic plasticity-related genes. The Phf21b-deficient mouse model exhibits impaired social memory and reduced expression of synaptic proteins, providing insights into potential therapeutic targets for neurobehavioral dysfunction.